UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of February 2024
Commission File Number: 001-41425
Golden Sun Health Technology Group Ltd
金太阳健康科技集团有限公司
8th Floor, Administration Building,
390 East Tiyuhui road, Hongkou District, China
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Resignation of Independent Director
Mr. Wenlong Xia, an independent director of Golden Sun Health Technology Group Ltd (the “Company”), notified the Company of his resignation from the board of directors of the Company (“Board”) on January 8, 2024, effective immediately. The Board is the process of appointing another independent director to fill the vacancy created by his departure.
1
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| Golden Sun Health Technology Group Ltd | ||
| Date: February 7, 2024 | By: |
/s/ Xueyuan Weng |
| Name: | Xueyuan Weng | |
| Title: | Chief Executive Officer | |
2